The Novo Nordisk AS diabetes drug approved by the FDA is Liraglutide. "FDA Approves Novo Nordisk Diabetes Drug's Use to Fight Obesity," at 4:15 p.m. EST, misstated the name of the drug in the second paragraph.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Novo Nordisk Charts.
Novo Nordisk (NYSE:NVO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Novo Nordisk Charts.